<p>A single adolescent patient with a BRAF V600E mutated brain tumor was treated with dabrafenib and had a complete response, followed by progression. The pre-treatment and post-progression tumors were both sequenced in order to identify potential drivers of resistance.</p>

Single Patient BRAF Mutant Brain Tumor, Pre- and Post-dabrafenib WES.

Ganglioglioma study with SNV (.MAF), WXS data on dbGaP (1 participants)